Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Viemed Healthcare Earnings Call: Key Takeaways

Viemed delivered record revenue of $80.7 million and 32% net income growth, driven by strong sleep therapy performance and maternal health expansion despite audit-related cash flow delays.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthTotal revenue up 12.2%; ventilator rentals $37.5M, up 7.4% year-over-year.
Mgmt ConfidenceHigh confidence in 4Q seasonality and maternal health rollout success.
Demand VisibilitySleep therapy patients up 37.5%; resupply patients up 22% year-over-year.
Margin TrendsAdjusted EBITDA margin 21.1%, expanded 350 basis points sequentially from 2Q.
Op. LeverageRevenue grew faster than SG&A; focus on volume through existing systems.
Vol vs PriceGrowth driven by volume; 43,861 PAP patients, up 6,000 sequentially.
Segment GrowthEquipment and supply sales grew 23.7% supported by sleep and women's health.
New ClientsAdded new distribution partner; expanding referral relationships in maternal health markets.
Capex & DebtLowered net capex outlook to 8-9% of revenue; repaid $2.1M debt.
RegulatoryIncreased audit activity across industry; management advocating for reduced provider burden.
CommentaryStrategic shift toward less capital-intensive sales and services to drive free cash.
New LaunchesEntering two additional states per quarter for maternal health starting 4Q.

Growth

Revenue grew 12.2% year-over-year to $80.7 million; net income rose 32% to $4.6 million.

Outlook

Raised full-year revenue guidance to $316M-$320M; targeting two-state maternal health expansion cadence per quarter.

Risks

Audit-related payment timing and system migrations increased accounts receivable, temporarily tying up working capital.

Source

The company's earnings call, NASDAQ: VMD, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Viemed Healthcare, Inc.: key numbers

Share price
$9.15Close, Nov 16
Market cap
$347M
Shares outstanding
37.89MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NECSIC 8090

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Viemed Healthcare, Inc.

All →
5:07 PM ET 10-Q
Financial Results ▶ Call

Viemed Healthcare Q3 2026 Results: Net Income $4.64M, Up 32.0% YoY

Viemed Healthcare reported a 20.7% increase in revenue for the nine months ended September 30, 2026, reaching $234.2 million compared to $194.1 million in the prior year. Net income attributable to the company grew to $10.0 million for the same period, while the company maintained a strong balance sheet with $150.1 million in total shareholders' equity.

Key figure
Net income $4.64M · +32.0% YoY
5:04 PM ET 8-K
Financial Results

Viemed Healthcare Financial Results

Viemed Healthcare reported record third-quarter 2026 net revenue of $80.7 million, a 12.2% year-over-year increase driven by growth in ventilator and PAP therapy patient volumes. The company raised the low end of its full-year 2026 revenue guidance to a range of $316 million to $320 million and improved its net capital expenditure outlook.

Term
Q3 2026

“Viemed delivered another record quarter, with revenue reaching $80.7 million and continued growth across our respiratory, sleep, and women's health businesses.”

Casey Hoyt, Viemed’s CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.